Using 5 alpha reductase inhibitors safely: What primary care physicians need to know

Area of Science:

• Pharmacology
• Endocrinology
• Dermatology

Background:

• 5 Alpha Reductase Inhibitors (ARIs) are frequently prescribed for benign prostatic hypertrophy, androgenetic alopecia, and hirsutism.
• Despite a general perception of safety, ARIs can cause persistent side effects, even after medication cessation.
• These potential adverse drug reactions are often overlooked as a cause of new clinical presentations.

Purpose of the Study:

• To raise awareness among primary care physicians about the common side effects associated with ARIs.
• To emphasize the importance of considering ARI-related adverse drug reactions in the differential diagnosis of new patient symptoms.
• To provide a concise overview of ARI side effects for primary care practitioners.

Main Methods:

• Literature review of documented side effects of 5 Alpha Reductase Inhibitors.
• Analysis of clinical case reports and pharmacological studies related to ARI adverse events.
• Synthesis of information to highlight common and persistent side effects.

Main Results:

• Identified a range of common side effects associated with ARI use.
• Highlighted that some side effects can persist long-term, even after discontinuing the medication.
• Emphasized the under-recognition of ARIs as a potential cause of persistent symptoms.

Conclusions:

• Primary care physicians should maintain a high index of suspicion for ARI-related adverse drug reactions.
• Considering ARI side effects is crucial for accurate diagnosis and management of new patient symptoms.
• Increased physician awareness can lead to better patient outcomes by addressing overlooked medication side effects.